Correlation Between BioInvent International and Active Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioInvent International and Active Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioInvent International and Active Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioInvent International AB and Active Biotech AB, you can compare the effects of market volatilities on BioInvent International and Active Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioInvent International with a short position of Active Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioInvent International and Active Biotech.

Diversification Opportunities for BioInvent International and Active Biotech

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between BioInvent and Active is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding BioInvent International AB and Active Biotech AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Active Biotech AB and BioInvent International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioInvent International AB are associated (or correlated) with Active Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Active Biotech AB has no effect on the direction of BioInvent International i.e., BioInvent International and Active Biotech go up and down completely randomly.

Pair Corralation between BioInvent International and Active Biotech

Assuming the 90 days trading horizon BioInvent International is expected to generate 3.29 times less return on investment than Active Biotech. But when comparing it to its historical volatility, BioInvent International AB is 2.52 times less risky than Active Biotech. It trades about 0.13 of its potential returns per unit of risk. Active Biotech AB is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  9.00  in Active Biotech AB on April 22, 2025 and sell it today you would earn a total of  12.00  from holding Active Biotech AB or generate 133.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

BioInvent International AB  vs.  Active Biotech AB

 Performance 
       Timeline  
BioInvent International 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in BioInvent International AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, BioInvent International unveiled solid returns over the last few months and may actually be approaching a breakup point.
Active Biotech AB 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Active Biotech AB are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Active Biotech unveiled solid returns over the last few months and may actually be approaching a breakup point.

BioInvent International and Active Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioInvent International and Active Biotech

The main advantage of trading using opposite BioInvent International and Active Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioInvent International position performs unexpectedly, Active Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Active Biotech will offset losses from the drop in Active Biotech's long position.
The idea behind BioInvent International AB and Active Biotech AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm